Clinical Trial Update: Efficacy and Safety of Teicoplanin in CDAD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating teicoplanin for Clostridioides difficile infection–associated diarrhea and colitis was terminated; no efficacy or safety conclusions ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Teicoplanin (Teicoplanin)

Snippet

Sponsor: Sanofi | Conditions: Clostridium Difficile Infection-associated Diarrhea and Colitis | Phase 4 | Status: TERMINATED